Balaji Venkataraman's Net Worth
$139 Million
Who is Balaji Venkataraman?
Balaji Venkataraman has an estimated net worth of $139 Million. This is based on reported shares across multiple companies, which include Horizon Pharma plc, Jasper Therapeutics, Inc., PROGENICS PHARMACEUTICALS INC, ALIMERA SCIENCES INC, and HERON THERAPEUTICS, INC. /DE/.
SEC CIK
Balaji Venkataraman's CIK is 0001114916
Past Insider Trading and Trends
2019 was Balaji Venkataraman's most active year for acquiring shares with 5 total transactions. Balaji Venkataraman's most active month to acquire stocks was the month of August. 2023 was Balaji Venkataraman's most active year for disposing of shares, totalling 3 transactions. Balaji Venkataraman's most active month to dispose stocks was the month of July. 2023 saw Balaji Venkataraman paying a total of $21,482,999.10 for 11,998,879 shares, this is the most they've acquired in one year. In 2014 Balaji Venkataraman cashed out on 6,086,957 shares for a total of $70,243,483.78, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Horizon Pharma plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -36.70% | -6.09M |
$11.54 | -$70,243,483.78 | 10.5M |
Nov 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jasper Therapeutics, Inc. (JSPR) Snapshot price: $17.505
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +41.74% | 350K |
$12.95 | $4,532,500.00 | 1.19M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 2.3M |
—
|
—
| 2.3M |
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROGENICS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.91% | 72.02K |
$4.99 | $359,733.28 | 8.01M |
Sep 9
| |||
Form 4
| +7.02% | 521.04K |
$4.45 | $2,317,446.44 | 7.94M |
Sep 3 - Sep 4
| |||
Form 4
| +2.83% | 204.06K |
$4.31 | $878,600.96 | 7.42M |
Aug 23 - Aug 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALIMERA SCIENCES INC (ALIM) Snapshot price: $3.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
| +719.96% | 11.95M |
$1.78 | $21,482,999.10 | 13.61M |
Aug 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $2.265
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||